ScholarIQanswers from OpenAlex & ORCID
Michael Fu
ResearcherPublications, citations & collaboration network
Michael Fu is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Michael Fu have?
ScholarIQindexed works
Michael Fu has 279 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Michael Fu have?
ScholarIQcitation count
Michael Fu has 18,390 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Michael Fu?
ScholarIQh-index
Michael Fu has an h-index of 49 in OpenAlex.
What is the i10-index of Michael Fu?
ScholarIQi10-index
Michael Fu has an i10-index of 155 in OpenAlex.
What is the ORCID of Michael Fu?
ScholarIQorcid
The ORCID for Michael Fu is on the source record.
What is the OpenAlex record for Michael Fu?
ScholarIQopenalex
The OpenAlex for Michael Fu is on the source record.
What are the most-cited papers on Michael Fu?
ScholarIQmost cited works
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
Alida L.P. Caforio, Sabine Pankuweit, Eloisa Arbustini, Cristina Basso, Juan R. Gimeno, Stephan B. Felix, Michael Fu, Tiina Heliö, Stéphane Heymans, Roland Jahns, Karin Klingel, Aleš Linhart, Bernhard Maisch, William J. McKenna, Jens Mogensen, Yigal M. Pinto, Arsen Ristić, Heinz‐Peter Schultheiß, Hubert Seggewiß, Luigi Tavazzi, Gaetano Thiene, Atilla Yılmaz, Philippe Charron, Perry Elliott
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Burkert Pieske, Carsten Tschöpe, Rudolf A. de Boer, Alan G. Fraser, Stefan D. Anker, Erwan Donal, Frank Edelmann, Michael Fu, Marco Guazzi, Carolyn S.P. Lam, Patrizio Lancellotti, Vojtěch Melenovský, Daniel A. Morris, Eike Nagel, Elisabeth Pieske‐Kraigher, Piotr Ponikowski, Scott D. Solomon, Ramachandran S. Vasan, Frans H. Rutten, Adriaan A. Voors, Frank Ruschitzka, Walter J. Paulus, Petar Seferović, Gerasimos Filippatos
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
Steven H J Hageman, Lisa Pennells, Francisco Ojeda, Stephen Kaptoge, Kari Kuulasmaa, Tamar I. de Vries, Zhe Xu, Frank Kee, Ryan Chung, Angela Wood, John W. McEvoy, Giovanni Veronesi, Thomas Bolton, Stephan Achenbach, Krasimira Aleksandrova, Pilar Amiano, Donostia-San Sebastián, Philippe Amouyel, Jonas Andersson, Stephan J. L. Bakker, Rui Bebiano Da Providencia Costa, Joline W. J. Beulens, Michael J. Blaha, Martin Bobák, Jolanda M.A. Boer, Catalina Bonet, Fabrice Bonnet, Marie‐Christine Boutron‐Ruault, Tonje Braaten, Hermann Brenner, Fabian J. Brunner, Eric J. Brunner, Mattias Brunström, Julie E. Buring, Adam S. Butterworth, Naděžda Čapková, Giancarlo Cesana, Christina Chrysohoou, Sandra M. Colorado‐Yohar, Nancy R. Cook, Cyrus Cooper, Christina C. Dahm, Karina W. Davidson, Elaine Dennison, Augusto Di Castelnuovo, Chiara Donfrancesco, Marcus Dörr, Agnieszka Doryńska, Mats Eliasson, Gunnar Engström, Pietro Ferrari, Maurizio Ferrario, Ian Ford, Michael Fu, Ron T. Gansevoort, Simona Giampaoli, Richard F. Gillum, Agustı́n Gómez de la Cámara, Guıdo Grassı, Per‐Olof Hansson, Radu Huculeci, Kristian Hveem, Licia Iacoviello, M. Kamran Ikram, Torben Jørgensen, Bijoy Joseph, Pekka Jousilahti, J. Wouter Jukema, Rudolf Kaaks, Verena Katzke, Maryam Kavousi, Stefan Kiechl, Jens Klotsche, Wolfgang König, Richard A. Kronmal, Růžena Kubínová, Anna Kucharska‐Newton, Kristi Läll, Nils Lehmann, David M. Leistner, Allan Linneberg, David Lora Pablos, Thiess Lorenz, Wentian Lu, Dalia Lukšienė, Magnus Nakrem Lyngbakken, Christina Magnussen, Sofia Malyutina, Alejandro Marín Ibañez, Giovanna Masala, Ellisiv B. Mathiesen, Kuni Matsushita, Tom Meade, Olle Melander, Helmut E. Meyer, Karel G.M. Moons, Conchi Moreno‐Iribas, David C. Muller, Thomas Münzel, Y.P. Nikitin
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity
Mikhail Kosiborod, Steen Z. Abildstrøm, Barry A. Borlaug, Javed Butler, Søren Rasmussen, Melanie J. Davies, G. Kees Hovingh, Dalane W. Kitzman, Marie L.S. Lindegaard, Daniél V. Møller, Sanjiv J. Shah, Marianne Bach Treppendahl, Subodh Verma, Walter P. Abhayaratna, Fozia Ahmed, Vijay Chopra, Justin A. Ezekowitz, Michael Fu, Hiroshi Ito, Małgorzata Lelonek, Vojtěch Melenovský, Béla Merkely, Julio Núñez, Eduardo Perna, Morten Schou, Michele Senni, Kavita Sharma, Peter van der Meer, Dirk von Lewinski, Dennis Wolf, Mark C. Petrie
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
Adriaan A. Voors, Christiane E. Angermann, John R. Teerlink, Sean P. Collins, Mikhail Kosiborod, Jan Biegus, João Pedro Ferreira, Michael E. Nassif, Mitchell A. Psotka, Jasper Tromp, C. Jan Willem Borleffs, Changsheng Ma, J COMINCOLET, Michael Fu, Stefan Janssens, Róbert Gábor Kiss, Robert J. Mentz, Yasushi Sakata, Henrik Schirmer, Morten Schou, P. Christian Schulze, Lenka Špinarová, Maurizio Volterrani, Jerzy Krzysztof Wranicz, Uwe Zeymer, Shelley Zieroth, Martina Brueckmann, Jon Blatchford, Afshin Salsali, Piotr Ponikowski